215 related articles for article (PubMed ID: 32303305)
21. Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses.
Durán-Ferrer M; Villalba R; Fernández-Pacheco P; Tena-Tomás C; Jiménez-Clavero MÁ; Bouzada JA; Ruano MJ; Fernández-Pinero J; Arias M; Castillo-Olivares J; Agüero M
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891525
[TBL] [Abstract][Full Text] [Related]
22. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
[TBL] [Abstract][Full Text] [Related]
23. Control and eradication of African horse sickness with vaccine.
Sánchez-Vizcaíno JM
Dev Biol (Basel); 2004; 119():255-8. PubMed ID: 15742636
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for African horse sickness vaccines for use in nonendemic areas.
House JA
Rev Elev Med Vet Pays Trop; 1993; 46(1-2):77-81. PubMed ID: 8134660
[TBL] [Abstract][Full Text] [Related]
25. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.
Kanai Y; van Rijn PA; Maris-Veldhuis M; Kaname Y; Athmaram TN; Roy P
Vaccine; 2014 Sep; 32(39):4932-7. PubMed ID: 25045805
[TBL] [Abstract][Full Text] [Related]
27. Future international management of African horse sickness vaccines.
House JA
Arch Virol Suppl; 1998; 14():297-304. PubMed ID: 9785514
[TBL] [Abstract][Full Text] [Related]
28. Comparative Genome Analysis of All Nine African Horse Sickness Serotypes Isolated From Equine Fatalities in Kenya and South Africa.
Hoffmann B; Joseph S; Patteril NAG; Caveney MR; Elizabeth SK; Muhammed R; Wernery R; Wernery U
J Equine Vet Sci; 2022 Dec; 119():104137. PubMed ID: 36223818
[TBL] [Abstract][Full Text] [Related]
29. Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.
Lulla V; Losada A; Lecollinet S; Kerviel A; Lilin T; Sailleau C; Beck C; Zientara S; Roy P
Vaccine; 2017 Jul; 35(33):4262-4269. PubMed ID: 28625521
[TBL] [Abstract][Full Text] [Related]
30. Development of a Microsphere-based Immunoassay for Serological Detection of African Horse Sickness Virus and Comparison with Other Diagnostic Techniques.
Sánchez-Matamoros A; Beck C; Kukielka D; Lecollinet S; Blaise-Boisseau S; Garnier A; Rueda P; Zientara S; Sánchez-Vizcaíno JM
Transbound Emerg Dis; 2016 Dec; 63(6):e270-e277. PubMed ID: 25693720
[TBL] [Abstract][Full Text] [Related]
31. An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
El Garch H; Crafford JE; Amouyal P; Durand PY; Edlund Toulemonde C; Lemaitre L; Cozette V; Guthrie A; Minke JM
Vet Immunol Immunopathol; 2012 Sep; 149(1-2):76-85. PubMed ID: 22763149
[TBL] [Abstract][Full Text] [Related]
32. African horse sickness in The Gambia: circulation of a live-attenuated vaccine-derived strain.
Oura CA; Ivens PA; Bachanek-Bankowska K; Bin-Tarif A; Jallow DB; Sailleau C; Maan S; Mertens PC; Batten CA
Epidemiol Infect; 2012 Mar; 140(3):462-5. PubMed ID: 21733265
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals.
Ronchi GF; Ulisse S; Rossi E; Franchi P; Armillotta G; Capista S; Peccio A; Di Ventura M; Pini A
Vet Ital; 2012; 48(1):55-76. PubMed ID: 22485003
[TBL] [Abstract][Full Text] [Related]
34. African horse sickness in naturally infected, immunised horses.
Weyer CT; Quan M; Joone C; Lourens CW; MacLachlan NJ; Guthrie AJ
Equine Vet J; 2013 Jan; 45(1):117-9. PubMed ID: 22612775
[TBL] [Abstract][Full Text] [Related]
35. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
36. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
[TBL] [Abstract][Full Text] [Related]
37. African horse sickness in Zimbabwe: 1972 to 1981.
Blackburn NK; Swanepoel R
Trop Anim Health Prod; 1988 Aug; 20(3):169-76. PubMed ID: 3194977
[TBL] [Abstract][Full Text] [Related]
38. African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.
Weyer CT; Grewar JD; Burger P; Rossouw E; Lourens C; Joone C; le Grange M; Coetzee P; Venter E; Martin DP; MacLachlan NJ; Guthrie AJ
Emerg Infect Dis; 2016 Dec; 22(12):2087-2096. PubMed ID: 27442883
[TBL] [Abstract][Full Text] [Related]
39. Use of reverse transcriptase-polymerase chain reaction (RT-PCR) and dot-blot hybridisation for the detection and identification of African horse sickness virus nucleic acids.
Zientara S; Sailleau C; Moulay S; Crucière C; el-Harrak M; Laegreid WW; Hamblin C
Arch Virol Suppl; 1998; 14():317-27. PubMed ID: 9785517
[TBL] [Abstract][Full Text] [Related]
40. Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice.
O'Kennedy MM; Roth R; Ebersohn K; du Plessis LH; Mamputha S; Rutkowska DA; du Preez I; Verschoor JA; Lemmer Y
PLoS One; 2024; 19(4):e0301340. PubMed ID: 38625924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
